Search

Your search keyword '"AKAR, Servet"' showing total 1,250 results

Search Constraints

Start Over You searched for: Author "AKAR, Servet" Remove constraint Author: "AKAR, Servet"
1,250 results on '"AKAR, Servet"'

Search Results

3. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

4. Assessing safety and efficacy of TNFi treatment in late onset ankylosing spondylitis: a TURKBIO registry study

5. Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study

10. Correction: Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

13. Comparison of methotrexate and azathioprine as the first-line steroid-sparing immunosuppressive agents in patients with Takayasu's arteritis

17. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)

20. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

22. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study

23. A national, multicenter, secondary data use study evaluating efficacy and retention of first-line biologic treatment with tocilizumab in patients with rheumatoid arthritis in real-life setting: results from TURKBIO registry

24. Comparison of Serum Nesfatin-1 and Visfatin Levels Between Patients with Rheumatoid Arthritis and Healthy Controls.

25. Secukinumab May Be an Effective Treatment Option for Axial Spondyloarthritis and Psoriatic Arthritis Patients with a History of Malignancy: Multicenter Real-Life Experience from Turkey.

26. Major Determinants of Well‐Being in Patients With Axial Spondyloarthritis: 2 Year Follow‐Up.

27. Validity and reliability of the Turkish version of Exercise Benefits/ Barriers Scale: Perceived exercise benefits and barriers of patients with different axial spondyloarthritis subtypes.

28. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

29. Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results

32. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?

35. Unveiling Cancer Risk in ANCA-Associated Vasculitis: Result from the Turkish Vasculitis Study Group (TRVaS)

38. Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five‐Year International Observational Study

41. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.

42. Factors associated with acute anterior uveitis history in patients with axial spondyloarthritis: Results of a longitudinal study.

44. Body mass index does not affect response of rituximab in patients with rheumatoid arthritis: results from the TURKBİO registry

46. Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

47. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib

50. The impact of smoking on response to tumor necrosis factor-α inhibitor treatment in patients with ankylosing spondylitis

Catalog

Books, media, physical & digital resources